nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—Cisplatin—lung cancer	0.321	1	CbGbCtD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—VIMP—lung cancer	0.0229	0.087	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—VIMP—lung cancer	0.0139	0.0527	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—ALK—lung cancer	0.0103	0.0393	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PRDX1—lung cancer	0.00894	0.0339	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—NFE2L2—lung cancer	0.00848	0.0322	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—AZIN2—lung cancer	0.00756	0.0287	CbGpPWpGaD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—CSF3—lung cancer	0.00708	0.0269	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—NODAL—lung cancer	0.00632	0.024	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—HSD17B10—lung cancer	0.00524	0.0199	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—VIMP—lung cancer	0.005	0.019	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—CKB—lung cancer	0.00487	0.0185	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—AZIN2—lung cancer	0.00462	0.0175	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—CNDP2—lung cancer	0.00458	0.0174	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—AZIN2—lung cancer	0.00434	0.0165	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—TF—lung cancer	0.00407	0.0155	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—PRDX1—lung cancer	0.00322	0.0122	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—HSD17B10—lung cancer	0.0032	0.0122	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—CAT—lung cancer	0.00301	0.0114	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—HSD17B10—lung cancer	0.00301	0.0114	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—CKB—lung cancer	0.00298	0.0113	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—SOD2—lung cancer	0.00286	0.0108	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—CNDP2—lung cancer	0.0028	0.0106	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—CKB—lung cancer	0.0028	0.0106	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—CNDP2—lung cancer	0.00263	0.00999	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—SKI—lung cancer	0.00245	0.00931	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—GCLC—lung cancer	0.00241	0.00913	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—JUN—lung cancer	0.00239	0.00907	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—APOA1—lung cancer	0.00231	0.00879	CbGpPWpGaD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—NQO1—lung cancer	0.00202	0.00768	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—KIT—lung cancer	0.00197	0.00748	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—EGF—lung cancer	0.00195	0.0074	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—ALB—lung cancer	0.00183	0.00696	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—IL6R—lung cancer	0.00183	0.00695	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—PTGS2—lung cancer	0.0016	0.00609	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—SOD2—lung cancer	0.00159	0.00604	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—GCLC—lung cancer	0.00147	0.00558	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AZIN2—lung cancer	0.00139	0.00527	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—COL4A3BP—lung cancer	0.00139	0.00527	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—GCLC—lung cancer	0.00138	0.00525	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—CAT—lung cancer	0.00137	0.00518	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—SOD2—lung cancer	0.00129	0.00491	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—APOA1—lung cancer	0.00129	0.00489	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—NQO1—lung cancer	0.00124	0.00469	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ATP5H—lung cancer	0.00118	0.00448	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—lung cancer	0.00118	0.00447	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—CD4—lung cancer	0.00116	0.00442	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—NQO1—lung cancer	0.00116	0.00441	CbGpPWpGaD
Propylthiouracil—Neuritis—Doxorubicin—lung cancer	0.00109	0.00262	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—CAT—lung cancer	0.00109	0.00412	CbGpPWpGaD
Propylthiouracil—Vertigo—Vinblastine—lung cancer	0.00108	0.0026	CcSEcCtD
Propylthiouracil—Leukopenia—Vinblastine—lung cancer	0.00108	0.00259	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL2—lung cancer	0.00107	0.00406	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—HES1—lung cancer	0.00107	0.00406	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—GSTM1—lung cancer	0.00106	0.00404	CbGpPWpGaD
Propylthiouracil—Hepatic failure—Docetaxel—lung cancer	0.00105	0.00253	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PLBD1—lung cancer	0.00105	0.00399	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—APOA1—lung cancer	0.00105	0.00398	CbGpPWpGaD
Propylthiouracil—Leukopenia—Topotecan—lung cancer	0.00105	0.00252	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—lung cancer	0.00105	0.00252	CcSEcCtD
Propylthiouracil—Nausea—Crizotinib—lung cancer	0.00103	0.00249	CcSEcCtD
Propylthiouracil—Jaundice—Irinotecan—lung cancer	0.00103	0.00248	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—SOD2—lung cancer	0.00103	0.0039	CbGpPWpGaD
Propylthiouracil—Urticaria—Teniposide—lung cancer	0.00102	0.00246	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—ALB—lung cancer	0.00102	0.00388	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Teniposide—lung cancer	0.00102	0.00245	CcSEcCtD
Propylthiouracil—Alopecia—Vinorelbine—lung cancer	0.00102	0.00244	CcSEcCtD
Propylthiouracil—Vomiting—Pemetrexed—lung cancer	0.00101	0.00243	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Gemcitabine—lung cancer	0.00101	0.00242	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—lung cancer	0.001	0.00242	CcSEcCtD
Propylthiouracil—Vomiting—Gefitinib—lung cancer	0.001	0.00242	CcSEcCtD
Propylthiouracil—Rash—Pemetrexed—lung cancer	0.001	0.00241	CcSEcCtD
Propylthiouracil—Dermatitis—Pemetrexed—lung cancer	0.001	0.00241	CcSEcCtD
Propylthiouracil—Rash—Gefitinib—lung cancer	0.000996	0.0024	CcSEcCtD
Propylthiouracil—Myalgia—Topotecan—lung cancer	0.000995	0.00239	CcSEcCtD
Propylthiouracil—Arthralgia—Topotecan—lung cancer	0.000995	0.00239	CcSEcCtD
Propylthiouracil—Dermatitis—Gefitinib—lung cancer	0.000995	0.00239	CcSEcCtD
Propylthiouracil—Arthralgia—Erlotinib—lung cancer	0.000985	0.00237	CcSEcCtD
Propylthiouracil—Myalgia—Erlotinib—lung cancer	0.000985	0.00237	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—lung cancer	0.000967	0.00233	CcSEcCtD
Propylthiouracil—Vasculitis—Methotrexate—lung cancer	0.000963	0.00232	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HSD17B10—lung cancer	0.000962	0.00365	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Vinblastine—lung cancer	0.000962	0.00231	CcSEcCtD
Propylthiouracil—Agranulocytosis—Gemcitabine—lung cancer	0.00096	0.00231	CcSEcCtD
Propylthiouracil—Haemoglobin—Irinotecan—lung cancer	0.000952	0.00229	CcSEcCtD
Propylthiouracil—Haemorrhage—Irinotecan—lung cancer	0.000948	0.00228	CcSEcCtD
Propylthiouracil—Oedema—Erlotinib—lung cancer	0.000944	0.00227	CcSEcCtD
Propylthiouracil—Nausea—Pemetrexed—lung cancer	0.000944	0.00227	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—IL6—lung cancer	0.000943	0.00358	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Cisplatin—lung cancer	0.000939	0.00226	CcSEcCtD
Propylthiouracil—Nausea—Gefitinib—lung cancer	0.000938	0.00226	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Topotecan—lung cancer	0.000934	0.00225	CcSEcCtD
Propylthiouracil—Haemoglobin—Gemcitabine—lung cancer	0.000928	0.00223	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Erlotinib—lung cancer	0.000924	0.00222	CcSEcCtD
Propylthiouracil—Haemorrhage—Gemcitabine—lung cancer	0.000923	0.00222	CcSEcCtD
Propylthiouracil—Pruritus—Teniposide—lung cancer	0.000911	0.00219	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT3—lung cancer	0.000901	0.00342	CbGpPWpGaD
Propylthiouracil—Vertigo—Vinorelbine—lung cancer	0.000899	0.00216	CcSEcCtD
Propylthiouracil—Leukopenia—Vinorelbine—lung cancer	0.000895	0.00215	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CKB—lung cancer	0.000895	0.0034	CbGpPWpGaD
Propylthiouracil—Aplastic anaemia—Methotrexate—lung cancer	0.000883	0.00212	CcSEcCtD
Propylthiouracil—Paraesthesia—Vinblastine—lung cancer	0.000882	0.00212	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IL6—lung cancer	0.000874	0.00332	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Topotecan—lung cancer	0.000869	0.00209	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Etoposide—lung cancer	0.000861	0.00207	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00086	0.00207	CcSEcCtD
Propylthiouracil—Paraesthesia—Topotecan—lung cancer	0.000857	0.00206	CcSEcCtD
Propylthiouracil—Jaundice—Etoposide—lung cancer	0.000856	0.00206	CcSEcCtD
Propylthiouracil—Myalgia—Vinorelbine—lung cancer	0.000852	0.00205	CcSEcCtD
Propylthiouracil—Arthralgia—Vinorelbine—lung cancer	0.000852	0.00205	CcSEcCtD
Propylthiouracil—DBH—Metabolism—AZIN2—lung cancer	0.000848	0.00322	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—COL4A3BP—lung cancer	0.000848	0.00322	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Paclitaxel—lung cancer	0.000844	0.00203	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTM2—lung cancer	0.000841	0.00319	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CNDP2—lung cancer	0.000841	0.00319	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Topotecan—lung cancer	0.00084	0.00202	CcSEcCtD
Propylthiouracil—Alopecia—Irinotecan—lung cancer	0.000837	0.00201	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—APOA1—lung cancer	0.000833	0.00316	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—ALB—lung cancer	0.000831	0.00315	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Erlotinib—lung cancer	0.000831	0.002	CcSEcCtD
Propylthiouracil—Agranulocytosis—Etoposide—lung cancer	0.000819	0.00197	CcSEcCtD
Propylthiouracil—Vomiting—Teniposide—lung cancer	0.000819	0.00197	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—MTMR3—lung cancer	0.000818	0.00311	CbGpPWpGaD
Propylthiouracil—Alopecia—Gemcitabine—lung cancer	0.000816	0.00196	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—IL6—lung cancer	0.000815	0.00309	CbGpPWpGaD
Propylthiouracil—Rash—Teniposide—lung cancer	0.000812	0.00195	CcSEcCtD
Propylthiouracil—Dermatitis—Teniposide—lung cancer	0.000811	0.00195	CcSEcCtD
Propylthiouracil—Headache—Teniposide—lung cancer	0.000807	0.00194	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Methotrexate—lung cancer	0.0008	0.00192	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Vinorelbine—lung cancer	0.000799	0.00192	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PGAM1—lung cancer	0.000797	0.00303	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AZIN2—lung cancer	0.000797	0.00303	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—COL4A3BP—lung cancer	0.000797	0.00303	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—KIT—lung cancer	0.00079	0.003	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Paclitaxel—lung cancer	0.000777	0.00187	CcSEcCtD
Propylthiouracil—Haemorrhage—Paclitaxel—lung cancer	0.000773	0.00186	CcSEcCtD
Propylthiouracil—Nausea—Teniposide—lung cancer	0.000765	0.00184	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—lung cancer	0.000764	0.00184	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP2A7—lung cancer	0.000761	0.00289	CbGpPWpGaD
Propylthiouracil—Alopecia—Cisplatin—lung cancer	0.00076	0.00183	CcSEcCtD
Propylthiouracil—Hepatic failure—Methotrexate—lung cancer	0.000759	0.00183	CcSEcCtD
Propylthiouracil—Urticaria—Topotecan—lung cancer	0.000758	0.00182	CcSEcCtD
Propylthiouracil—Body temperature increased—Topotecan—lung cancer	0.000754	0.00181	CcSEcCtD
Propylthiouracil—Body temperature increased—Erlotinib—lung cancer	0.000746	0.0018	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SDC4—lung cancer	0.000744	0.00283	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000744	0.00179	CcSEcCtD
Propylthiouracil—Vertigo—Irinotecan—lung cancer	0.000741	0.00178	CcSEcCtD
Propylthiouracil—Renal failure acute—Methotrexate—lung cancer	0.000739	0.00178	CcSEcCtD
Propylthiouracil—Leukopenia—Irinotecan—lung cancer	0.000738	0.00178	CcSEcCtD
Propylthiouracil—Paraesthesia—Vinorelbine—lung cancer	0.000733	0.00176	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CREBBP—lung cancer	0.000732	0.00278	CbGpPWpGaD
Propylthiouracil—Dermatitis exfoliative—Methotrexate—lung cancer	0.000723	0.00174	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ATP5H—lung cancer	0.000721	0.00274	CbGpPWpGaD
Propylthiouracil—Leukopenia—Gemcitabine—lung cancer	0.000719	0.00173	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Docetaxel—lung cancer	0.000715	0.00172	CcSEcCtD
Propylthiouracil—Jaundice—Docetaxel—lung cancer	0.000711	0.00171	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—lung cancer	0.000711	0.0027	CbGpPWpGaD
Propylthiouracil—Alopecia—Etoposide—lung cancer	0.000696	0.00168	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Doxorubicin—lung cancer	0.000693	0.00167	CcSEcCtD
Propylthiouracil—Myalgia—Gemcitabine—lung cancer	0.000684	0.00165	CcSEcCtD
Propylthiouracil—Arthralgia—Gemcitabine—lung cancer	0.000684	0.00165	CcSEcCtD
Propylthiouracil—Alopecia—Paclitaxel—lung cancer	0.000683	0.00164	CcSEcCtD
Propylthiouracil—Agranulocytosis—Docetaxel—lung cancer	0.000681	0.00164	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—RRM1—lung cancer	0.000678	0.00257	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTA3—lung cancer	0.000678	0.00257	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ATP5H—lung cancer	0.000678	0.00257	CbGpPWpGaD
Propylthiouracil—Pruritus—Topotecan—lung cancer	0.000675	0.00162	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IL2—lung cancer	0.000674	0.00256	CbGpPWpGaD
Propylthiouracil—Oedema—Irinotecan—lung cancer	0.000673	0.00162	CcSEcCtD
Propylthiouracil—Dysgeusia—Etoposide—lung cancer	0.000672	0.00162	CcSEcCtD
Propylthiouracil—Leukopenia—Cisplatin—lung cancer	0.00067	0.00161	CcSEcCtD
Propylthiouracil—Pruritus—Erlotinib—lung cancer	0.000668	0.00161	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—ALB—lung cancer	0.00066	0.00251	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Irinotecan—lung cancer	0.000659	0.00159	CcSEcCtD
Propylthiouracil—Dysgeusia—Paclitaxel—lung cancer	0.000659	0.00158	CcSEcCtD
Propylthiouracil—Haemoglobin—Docetaxel—lung cancer	0.000658	0.00158	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—lung cancer	0.000658	0.00158	CcSEcCtD
Propylthiouracil—Oedema—Gemcitabine—lung cancer	0.000656	0.00158	CcSEcCtD
Propylthiouracil—Haemorrhage—Docetaxel—lung cancer	0.000655	0.00158	CcSEcCtD
Propylthiouracil—Hepatitis—Docetaxel—lung cancer	0.000655	0.00158	CcSEcCtD
Propylthiouracil—Urticaria—Vinorelbine—lung cancer	0.000648	0.00156	CcSEcCtD
Propylthiouracil—Body temperature increased—Vinorelbine—lung cancer	0.000645	0.00155	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PLBD1—lung cancer	0.000643	0.00244	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Gemcitabine—lung cancer	0.000642	0.00154	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN2A—lung cancer	0.000641	0.00243	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Doxorubicin—lung cancer	0.00064	0.00154	CcSEcCtD
Propylthiouracil—Myalgia—Cisplatin—lung cancer	0.000638	0.00153	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—B4GALT5—lung cancer	0.000638	0.00242	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL6—lung cancer	0.000629	0.00239	CbGpPWpGaD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000626	0.00151	CcSEcCtD
Propylthiouracil—Vomiting—Vinblastine—lung cancer	0.000625	0.0015	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA4—lung cancer	0.00062	0.00235	CbGpPWpGaD
Propylthiouracil—Vertigo—Etoposide—lung cancer	0.000616	0.00148	CcSEcCtD
Propylthiouracil—Headache—Vinblastine—lung cancer	0.000615	0.00148	CcSEcCtD
Propylthiouracil—Leukopenia—Etoposide—lung cancer	0.000614	0.00148	CcSEcCtD
Propylthiouracil—Oedema—Cisplatin—lung cancer	0.000611	0.00147	CcSEcCtD
Propylthiouracil—Vomiting—Topotecan—lung cancer	0.000607	0.00146	CcSEcCtD
Propylthiouracil—Paraesthesia—Irinotecan—lung cancer	0.000605	0.00145	CcSEcCtD
Propylthiouracil—Vertigo—Paclitaxel—lung cancer	0.000604	0.00145	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA2—lung cancer	0.000604	0.00229	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PLBD1—lung cancer	0.000604	0.00229	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CD4—lung cancer	0.000604	0.00229	CbGpPWpGaD
Propylthiouracil—Leukopenia—Paclitaxel—lung cancer	0.000602	0.00145	CcSEcCtD
Propylthiouracil—Rash—Topotecan—lung cancer	0.000602	0.00145	CcSEcCtD
Propylthiouracil—Dermatitis—Topotecan—lung cancer	0.000601	0.00145	CcSEcCtD
Propylthiouracil—Vomiting—Erlotinib—lung cancer	0.0006	0.00144	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—PTGS2—lung cancer	0.0006	0.00228	CbGpPWpGaD
Propylthiouracil—Somnolence—Irinotecan—lung cancer	0.000598	0.00144	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Cisplatin—lung cancer	0.000598	0.00144	CcSEcCtD
Propylthiouracil—Headache—Topotecan—lung cancer	0.000598	0.00144	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000597	0.00144	CcSEcCtD
Propylthiouracil—Rash—Erlotinib—lung cancer	0.000595	0.00143	CcSEcCtD
Propylthiouracil—Dermatitis—Erlotinib—lung cancer	0.000595	0.00143	CcSEcCtD
Propylthiouracil—Dyspepsia—Irinotecan—lung cancer	0.000593	0.00143	CcSEcCtD
Propylthiouracil—Headache—Erlotinib—lung cancer	0.000591	0.00142	CcSEcCtD
Propylthiouracil—Paraesthesia—Gemcitabine—lung cancer	0.000589	0.00142	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HSD17B10—lung cancer	0.000588	0.00223	CbGpPWpGaD
Propylthiouracil—Nausea—Vinblastine—lung cancer	0.000583	0.0014	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTA1—lung cancer	0.000583	0.00221	CbGpPWpGaD
Propylthiouracil—Somnolence—Gemcitabine—lung cancer	0.000583	0.0014	CcSEcCtD
Propylthiouracil—Alopecia—Docetaxel—lung cancer	0.000579	0.00139	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—PTGS2—lung cancer	0.000578	0.00219	CbGpPWpGaD
Propylthiouracil—Pruritus—Vinorelbine—lung cancer	0.000578	0.00139	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ABCC3—lung cancer	0.000577	0.00219	CbGpPWpGaD
Propylthiouracil—Arthralgia—Paclitaxel—lung cancer	0.000573	0.00138	CcSEcCtD
Propylthiouracil—Myalgia—Paclitaxel—lung cancer	0.000573	0.00138	CcSEcCtD
Propylthiouracil—Nausea—Topotecan—lung cancer	0.000567	0.00136	CcSEcCtD
Propylthiouracil—Nausea—Erlotinib—lung cancer	0.000561	0.00135	CcSEcCtD
Propylthiouracil—Dysgeusia—Docetaxel—lung cancer	0.000558	0.00134	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—AKR1C1—lung cancer	0.000558	0.00212	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000557	0.00134	CcSEcCtD
Propylthiouracil—TPO—Metabolism—HSD17B10—lung cancer	0.000553	0.0021	CbGpPWpGaD
Propylthiouracil—Oedema—Paclitaxel—lung cancer	0.000549	0.00132	CcSEcCtD
Propylthiouracil—Paraesthesia—Cisplatin—lung cancer	0.000549	0.00132	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Etoposide—lung cancer	0.000548	0.00132	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CKB—lung cancer	0.000547	0.00207	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—UGT1A1—lung cancer	0.000542	0.00206	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—lung cancer	0.000542	0.00206	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Paclitaxel—lung cancer	0.000538	0.00129	CcSEcCtD
Propylthiouracil—Body temperature increased—Irinotecan—lung cancer	0.000532	0.00128	CcSEcCtD
Propylthiouracil—Drowsiness—Methotrexate—lung cancer	0.000526	0.00127	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1A—lung cancer	0.000524	0.00199	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GNG11—lung cancer	0.000523	0.00198	CbGpPWpGaD
Propylthiouracil—Vomiting—Vinorelbine—lung cancer	0.000519	0.00125	CcSEcCtD
Propylthiouracil—Body temperature increased—Gemcitabine—lung cancer	0.000518	0.00125	CcSEcCtD
Propylthiouracil—Rash—Vinorelbine—lung cancer	0.000515	0.00124	CcSEcCtD
Propylthiouracil—Dermatitis—Vinorelbine—lung cancer	0.000514	0.00124	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CKB—lung cancer	0.000514	0.00195	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTM2—lung cancer	0.000514	0.00195	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CNDP2—lung cancer	0.000514	0.00195	CbGpPWpGaD
Propylthiouracil—Headache—Vinorelbine—lung cancer	0.000511	0.00123	CcSEcCtD
Propylthiouracil—Leukopenia—Docetaxel—lung cancer	0.00051	0.00123	CcSEcCtD
Propylthiouracil—Paraesthesia—Etoposide—lung cancer	0.000503	0.00121	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.0005	0.0012	CcSEcCtD
Propylthiouracil—DBH—Metabolism—MTMR3—lung cancer	0.0005	0.0019	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—EP300—lung cancer	0.000499	0.00189	CbGpPWpGaD
Propylthiouracil—Somnolence—Etoposide—lung cancer	0.000498	0.0012	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ALDOA—lung cancer	0.000498	0.00189	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Paclitaxel—lung cancer	0.000493	0.00119	CcSEcCtD
Propylthiouracil—Agranulocytosis—Methotrexate—lung cancer	0.000491	0.00118	CcSEcCtD
Propylthiouracil—Somnolence—Paclitaxel—lung cancer	0.000488	0.00117	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PGAM1—lung cancer	0.000487	0.00185	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL6—lung cancer	0.000487	0.00185	CbGpPWpGaD
Propylthiouracil—Arthralgia—Docetaxel—lung cancer	0.000485	0.00117	CcSEcCtD
Propylthiouracil—Myalgia—Docetaxel—lung cancer	0.000485	0.00117	CcSEcCtD
Propylthiouracil—Nausea—Vinorelbine—lung cancer	0.000485	0.00117	CcSEcCtD
Propylthiouracil—Dyspepsia—Paclitaxel—lung cancer	0.000483	0.00116	CcSEcCtD
Propylthiouracil—Body temperature increased—Cisplatin—lung cancer	0.000483	0.00116	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—NCOA3—lung cancer	0.000483	0.00183	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CNDP2—lung cancer	0.000483	0.00183	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTM2—lung cancer	0.000483	0.00183	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Methotrexate—lung cancer	0.000475	0.00114	CcSEcCtD
Propylthiouracil—Haemorrhage—Methotrexate—lung cancer	0.000472	0.00114	CcSEcCtD
Propylthiouracil—Hepatitis—Methotrexate—lung cancer	0.000472	0.00114	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ABCG2—lung cancer	0.00047	0.00178	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ADCY1—lung cancer	0.00047	0.00178	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTMR3—lung cancer	0.00047	0.00178	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—NRAS—lung cancer	0.000467	0.00177	CbGpPWpGaD
Propylthiouracil—Oedema—Docetaxel—lung cancer	0.000465	0.00112	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP2A7—lung cancer	0.000465	0.00176	CbGpPWpGaD
Propylthiouracil—Pruritus—Gemcitabine—lung cancer	0.000464	0.00112	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HPGDS—lung cancer	0.000461	0.00175	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ENO2—lung cancer	0.000461	0.00175	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PPP2R1B—lung cancer	0.000458	0.00174	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PGAM1—lung cancer	0.000458	0.00174	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Docetaxel—lung cancer	0.000456	0.0011	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—lung cancer	0.000455	0.0011	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SDC4—lung cancer	0.000455	0.00173	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTT1—lung cancer	0.000447	0.0017	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—lung cancer	0.000446	0.00107	CcSEcCtD
Propylthiouracil—Urticaria—Etoposide—lung cancer	0.000445	0.00107	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—lung cancer	0.000444	0.00107	CcSEcCtD
Propylthiouracil—Body temperature increased—Etoposide—lung cancer	0.000443	0.00106	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GCLC—lung cancer	0.000442	0.00168	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP2A6—lung cancer	0.000442	0.00168	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2A7—lung cancer	0.000437	0.00166	CbGpPWpGaD
Propylthiouracil—Urticaria—Paclitaxel—lung cancer	0.000436	0.00105	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—lung cancer	0.000435	0.00165	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Paclitaxel—lung cancer	0.000434	0.00104	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—TP53—lung cancer	0.000433	0.00164	CbGpPWpGaD
Propylthiouracil—Vomiting—Irinotecan—lung cancer	0.000428	0.00103	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SDC4—lung cancer	0.000428	0.00162	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Doxorubicin—lung cancer	0.000425	0.00102	CcSEcCtD
Propylthiouracil—Rash—Irinotecan—lung cancer	0.000424	0.00102	CcSEcCtD
Propylthiouracil—Dermatitis—Irinotecan—lung cancer	0.000424	0.00102	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000424	0.00102	CcSEcCtD
Propylthiouracil—Headache—Irinotecan—lung cancer	0.000422	0.00101	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ENO1—lung cancer	0.000419	0.00159	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Docetaxel—lung cancer	0.000418	0.00101	CcSEcCtD
Propylthiouracil—Alopecia—Methotrexate—lung cancer	0.000417	0.001	CcSEcCtD
Propylthiouracil—Vomiting—Gemcitabine—lung cancer	0.000417	0.001	CcSEcCtD
Propylthiouracil—DBH—Metabolism—RRM1—lung cancer	0.000414	0.00157	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA3—lung cancer	0.000414	0.00157	CbGpPWpGaD
Propylthiouracil—Somnolence—Docetaxel—lung cancer	0.000414	0.000995	CcSEcCtD
Propylthiouracil—Rash—Gemcitabine—lung cancer	0.000413	0.000995	CcSEcCtD
Propylthiouracil—Dermatitis—Gemcitabine—lung cancer	0.000413	0.000994	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—lung cancer	0.000411	0.000988	CcSEcCtD
Propylthiouracil—Headache—Gemcitabine—lung cancer	0.000411	0.000988	CcSEcCtD
Propylthiouracil—Dyspepsia—Docetaxel—lung cancer	0.00041	0.000986	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—lung cancer	0.000409	0.000983	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—lung cancer	0.000409	0.000983	CcSEcCtD
Propylthiouracil—Dysgeusia—Methotrexate—lung cancer	0.000402	0.000968	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—lung cancer	0.000402	0.00152	CbGpPWpGaD
Propylthiouracil—Nausea—Irinotecan—lung cancer	0.0004	0.000962	CcSEcCtD
Propylthiouracil—Pruritus—Etoposide—lung cancer	0.000396	0.000953	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IL6—lung cancer	0.000396	0.0015	CbGpPWpGaD
Propylthiouracil—Nausea—Gemcitabine—lung cancer	0.00039	0.000937	CcSEcCtD
Propylthiouracil—DBH—Metabolism—B4GALT5—lung cancer	0.000389	0.00148	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—RRM1—lung cancer	0.000389	0.00148	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA3—lung cancer	0.000389	0.00148	CbGpPWpGaD
Propylthiouracil—Vomiting—Cisplatin—lung cancer	0.000389	0.000935	CcSEcCtD
Propylthiouracil—Pruritus—Paclitaxel—lung cancer	0.000388	0.000935	CcSEcCtD
Propylthiouracil—Rash—Cisplatin—lung cancer	0.000385	0.000927	CcSEcCtD
Propylthiouracil—Dermatitis—Cisplatin—lung cancer	0.000385	0.000926	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTA4—lung cancer	0.000379	0.00144	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP2E1—lung cancer	0.000376	0.00143	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NQO1—lung cancer	0.000372	0.00141	CbGpPWpGaD
Propylthiouracil—Vertigo—Methotrexate—lung cancer	0.000369	0.000888	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTA2—lung cancer	0.000369	0.0014	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Docetaxel—lung cancer	0.000368	0.000885	CcSEcCtD
Propylthiouracil—Leukopenia—Methotrexate—lung cancer	0.000368	0.000885	CcSEcCtD
Propylthiouracil—TPO—Metabolism—B4GALT5—lung cancer	0.000366	0.00139	CbGpPWpGaD
Propylthiouracil—Nausea—Cisplatin—lung cancer	0.000363	0.000873	CcSEcCtD
Propylthiouracil—Alopecia—Doxorubicin—lung cancer	0.000361	0.000869	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTA4—lung cancer	0.000356	0.00135	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTA1—lung cancer	0.000356	0.00135	CbGpPWpGaD
Propylthiouracil—Vomiting—Etoposide—lung cancer	0.000356	0.000857	CcSEcCtD
Propylthiouracil—Rash—Etoposide—lung cancer	0.000353	0.000849	CcSEcCtD
Propylthiouracil—Dermatitis—Etoposide—lung cancer	0.000353	0.000849	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ABCC3—lung cancer	0.000352	0.00134	CbGpPWpGaD
Propylthiouracil—Headache—Etoposide—lung cancer	0.000351	0.000844	CcSEcCtD
Propylthiouracil—Myalgia—Methotrexate—lung cancer	0.00035	0.000842	CcSEcCtD
Propylthiouracil—Arthralgia—Methotrexate—lung cancer	0.00035	0.000842	CcSEcCtD
Propylthiouracil—Vomiting—Paclitaxel—lung cancer	0.000349	0.00084	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—lung cancer	0.000348	0.000838	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTA2—lung cancer	0.000347	0.00132	CbGpPWpGaD
Propylthiouracil—Rash—Paclitaxel—lung cancer	0.000346	0.000833	CcSEcCtD
Propylthiouracil—Dermatitis—Paclitaxel—lung cancer	0.000346	0.000832	CcSEcCtD
Propylthiouracil—Headache—Paclitaxel—lung cancer	0.000344	0.000827	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—lung cancer	0.000341	0.0013	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKR1C1—lung cancer	0.000341	0.00129	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—STK11—lung cancer	0.000335	0.00127	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTA1—lung cancer	0.000335	0.00127	CbGpPWpGaD
Propylthiouracil—Nausea—Etoposide—lung cancer	0.000333	0.0008	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ABCC3—lung cancer	0.000331	0.00126	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—UGT1A1—lung cancer	0.000331	0.00126	CbGpPWpGaD
Propylthiouracil—Pruritus—Docetaxel—lung cancer	0.000329	0.000792	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Methotrexate—lung cancer	0.000328	0.00079	CcSEcCtD
Propylthiouracil—Nausea—Paclitaxel—lung cancer	0.000326	0.000785	CcSEcCtD
Propylthiouracil—TPO—Metabolism—AKR1C1—lung cancer	0.000321	0.00122	CbGpPWpGaD
Propylthiouracil—Vertigo—Doxorubicin—lung cancer	0.00032	0.000769	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GNG11—lung cancer	0.000319	0.00121	CbGpPWpGaD
Propylthiouracil—Leukopenia—Doxorubicin—lung cancer	0.000319	0.000766	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL6—lung cancer	0.000315	0.00119	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—UGT1A1—lung cancer	0.000311	0.00118	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTP1—lung cancer	0.00031	0.00118	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000306	0.000735	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ALDOA—lung cancer	0.000304	0.00115	CbGpPWpGaD
Propylthiouracil—Arthralgia—Doxorubicin—lung cancer	0.000303	0.000729	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—lung cancer	0.000303	0.000729	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CAT—lung cancer	0.000302	0.00114	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Methotrexate—lung cancer	0.000301	0.000725	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GNG11—lung cancer	0.0003	0.00114	CbGpPWpGaD
Propylthiouracil—Somnolence—Methotrexate—lung cancer	0.000298	0.000717	CcSEcCtD
Propylthiouracil—Vomiting—Docetaxel—lung cancer	0.000296	0.000712	CcSEcCtD
Propylthiouracil—Dyspepsia—Methotrexate—lung cancer	0.000295	0.00071	CcSEcCtD
Propylthiouracil—DBH—Metabolism—NCOA3—lung cancer	0.000295	0.00112	CbGpPWpGaD
Propylthiouracil—Rash—Docetaxel—lung cancer	0.000293	0.000706	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ABCB1—lung cancer	0.000293	0.00111	CbGpPWpGaD
Propylthiouracil—Dermatitis—Docetaxel—lung cancer	0.000293	0.000705	CcSEcCtD
Propylthiouracil—Headache—Docetaxel—lung cancer	0.000292	0.000701	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—lung cancer	0.00029	0.000699	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—TYMS—lung cancer	0.000288	0.00109	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ADCY1—lung cancer	0.000287	0.00109	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCG2—lung cancer	0.000287	0.00109	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALDOA—lung cancer	0.000286	0.00108	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTM1—lung cancer	0.000285	0.00108	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Doxorubicin—lung cancer	0.000284	0.000684	CcSEcCtD
Propylthiouracil—DBH—Metabolism—HPGDS—lung cancer	0.000282	0.00107	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ENO2—lung cancer	0.000282	0.00107	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PPP2R1B—lung cancer	0.00028	0.00106	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOA3—lung cancer	0.000277	0.00105	CbGpPWpGaD
Propylthiouracil—Nausea—Docetaxel—lung cancer	0.000276	0.000665	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTT1—lung cancer	0.000273	0.00104	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GCLC—lung cancer	0.00027	0.00102	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYP1A1—lung cancer	0.00027	0.00102	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP2A6—lung cancer	0.00027	0.00102	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ADCY1—lung cancer	0.00027	0.00102	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCG2—lung cancer	0.00027	0.00102	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ERCC2—lung cancer	0.000268	0.00102	CbGpPWpGaD
Propylthiouracil—Urticaria—Methotrexate—lung cancer	0.000266	0.000641	CcSEcCtD
Propylthiouracil—Body temperature increased—Methotrexate—lung cancer	0.000265	0.000638	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ENO2—lung cancer	0.000265	0.001	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HPGDS—lung cancer	0.000265	0.001	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000265	0.000637	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PPP2R1B—lung cancer	0.000263	0.000998	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Doxorubicin—lung cancer	0.000261	0.000627	CcSEcCtD
Propylthiouracil—Somnolence—Doxorubicin—lung cancer	0.000258	0.000621	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTT1—lung cancer	0.000257	0.000974	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ENO1—lung cancer	0.000256	0.000971	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Doxorubicin—lung cancer	0.000256	0.000615	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CYP2A6—lung cancer	0.000254	0.000963	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GCLC—lung cancer	0.000254	0.000963	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ENO1—lung cancer	0.000241	0.000913	CbGpPWpGaD
Propylthiouracil—Pruritus—Methotrexate—lung cancer	0.000237	0.000571	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—APOA1—lung cancer	0.000232	0.000879	CbGpPWpGaD
Propylthiouracil—Urticaria—Doxorubicin—lung cancer	0.000231	0.000555	CcSEcCtD
Propylthiouracil—Body temperature increased—Doxorubicin—lung cancer	0.00023	0.000552	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYP2E1—lung cancer	0.00023	0.000871	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NQO1—lung cancer	0.000227	0.000861	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP2E1—lung cancer	0.000216	0.000819	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NQO1—lung cancer	0.000213	0.00081	CbGpPWpGaD
Propylthiouracil—Vomiting—Methotrexate—lung cancer	0.000213	0.000513	CcSEcCtD
Propylthiouracil—Rash—Methotrexate—lung cancer	0.000211	0.000509	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PIK3CG—lung cancer	0.000211	0.000802	CbGpPWpGaD
Propylthiouracil—Dermatitis—Methotrexate—lung cancer	0.000211	0.000508	CcSEcCtD
Propylthiouracil—Headache—Methotrexate—lung cancer	0.00021	0.000506	CcSEcCtD
Propylthiouracil—Pruritus—Doxorubicin—lung cancer	0.000205	0.000494	CcSEcCtD
Propylthiouracil—DBH—Metabolism—STK11—lung cancer	0.000205	0.000776	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—POMC—lung cancer	0.000201	0.000764	CbGpPWpGaD
Propylthiouracil—Nausea—Methotrexate—lung cancer	0.000199	0.000479	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CREBBP—lung cancer	0.000196	0.000744	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—STK11—lung cancer	0.000192	0.00073	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTP1—lung cancer	0.000189	0.000718	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CD—lung cancer	0.000186	0.000705	CbGpPWpGaD
Propylthiouracil—Vomiting—Doxorubicin—lung cancer	0.000185	0.000444	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CAT—lung cancer	0.000184	0.000699	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALB—lung cancer	0.000183	0.000696	CbGpPWpGaD
Propylthiouracil—Rash—Doxorubicin—lung cancer	0.000183	0.000441	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—lung cancer	0.000183	0.00044	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—lung cancer	0.000182	0.000438	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ABCB1—lung cancer	0.000179	0.00068	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTP1—lung cancer	0.000178	0.000675	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TYMS—lung cancer	0.000176	0.000668	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTM1—lung cancer	0.000174	0.00066	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CAT—lung cancer	0.000173	0.000657	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—lung cancer	0.000173	0.000415	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ABCB1—lung cancer	0.000168	0.000639	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TYMS—lung cancer	0.000165	0.000628	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP1A1—lung cancer	0.000165	0.000626	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTM1—lung cancer	0.000164	0.000621	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ERCC2—lung cancer	0.000164	0.000621	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—lung cancer	0.000162	0.000615	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTGS2—lung cancer	0.000161	0.000609	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CYP1A1—lung cancer	0.000155	0.000588	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ERCC2—lung cancer	0.000154	0.000584	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—APOA1—lung cancer	0.000141	0.000537	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTEN—lung cancer	0.00014	0.000531	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—EP300—lung cancer	0.000134	0.000507	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—APOA1—lung cancer	0.000133	0.000505	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CG—lung cancer	0.000129	0.00049	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—POMC—lung cancer	0.000123	0.000467	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CG—lung cancer	0.000121	0.000461	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CREBBP—lung cancer	0.00012	0.000454	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—POMC—lung cancer	0.000116	0.000439	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—lung cancer	0.000114	0.000431	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CREBBP—lung cancer	0.000113	0.000427	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALB—lung cancer	0.000112	0.000425	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—lung cancer	0.000107	0.000405	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALB—lung cancer	0.000105	0.0004	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—lung cancer	9.9e-05	0.000376	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—lung cancer	9.88e-05	0.000375	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTGS2—lung cancer	9.81e-05	0.000372	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—lung cancer	9.31e-05	0.000353	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTGS2—lung cancer	9.22e-05	0.00035	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—lung cancer	8.55e-05	0.000325	CbGpPWpGaD
Propylthiouracil—DIO1—lung—lung cancer	8.42e-05	0.399	CbGeAlD
Propylthiouracil—DBH—Metabolism—EP300—lung cancer	8.16e-05	0.00031	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—lung cancer	8.07e-05	0.000306	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—lung cancer	8.04e-05	0.000305	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—EP300—lung cancer	7.67e-05	0.000291	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—lung cancer	6.03e-05	0.000229	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—lung cancer	5.67e-05	0.000215	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—lung cancer	4.93e-05	0.000187	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—lung cancer	4.63e-05	0.000176	CbGpPWpGaD
Propylthiouracil—DBH—bone marrow—lung cancer	2.73e-05	0.129	CbGeAlD
Propylthiouracil—MPO—respiratory system—lung cancer	2.49e-05	0.118	CbGeAlD
Propylthiouracil—MPO—epithelium—lung cancer	2.08e-05	0.0987	CbGeAlD
Propylthiouracil—DBH—lymph node—lung cancer	1.69e-05	0.0802	CbGeAlD
Propylthiouracil—MPO—bone marrow—lung cancer	1.46e-05	0.0692	CbGeAlD
Propylthiouracil—MPO—lung—lung cancer	1.32e-05	0.0627	CbGeAlD
Propylthiouracil—MPO—lymph node—lung cancer	9.05e-06	0.0429	CbGeAlD
